comparemela.com

Latest Breaking News On - Arthritis study - Page 1 : comparemela.com

Positive Top-Line Results for bimekizumab in Second Phase 3 Psoriatic Arthritis Study

/PRNewswire/ UCB, a global biopharmaceutical company, today announced positive top-line results from the Phase 3 BE COMPLETE study, which evaluated the.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.